Clinical Trial: Investigation of the Regulatory Mechanism of Gut Microbiota and Its Metabolites in Elderly Sarcopenia Based on the 'Spleen-Fat-Muscle' Metabolic Theory (China)

Posted On: 2026-08-10

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Investigation of the Regulatory Mechanism of Gut Microbiota and Its Metabolites in Elderly Sarcopenia Based on the 'Spleen-Fat-Muscle' Metabolic Theory'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129688

Registration Time: 2026/08/07

Type: Observational study

Primary Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=318704

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Investigation of the Regulatory Mechanism of Gut Microbiota and Its Metabolites in Elderly Sarcopenia Based on the 'Spleen-Fat-Muscle' Metabolic Theory (China)